Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

Clinical trial NCT04776850 · WITHDRAWN

Trial details

NCT number: NCT04776850
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Beta Thalassemia Major Sickle Beta 0 Thalassemia Sickle Beta Plus Thalassemia Sickle Beta Thalassemia Sickle Cell Disease Sickle Cell-SS Disease

Start date: 2020-12-29
Primary completion: 2022-12-05
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.